RSS
retinitis pigmentosa (RP)
ReNeuron wins grant to advance development of stem cell therapy
UK-based developer of cell-based therapeutics, ReNeuron Group, has won a grant to advance the development of its hRPC stem cell therapy candidate for blindness-causing degenerative diseases of the retina. Read more
Agreement formed for development of AAV vectors for ocular gene therapy
German-based company, SIRION Biotech has signed a two-year development agreement with a clinical-stage ophthalmology company, Acucela, to establish optimised adeno associated virus (AAV) vectors for clinical applications in ocular gene therapy. Read more
